Wrist tracking model detected Parkinson’s in people
The model scored 0.93 on a measure of how well it distinguished 133 people with Parkinson’s from 26 healthy controls.

Our read
Biomarkers- Studied:
- Preprint: case-control study of people with Parkinson’s disease and healthy controls, against healthy controls
- What changed:
- The model scored 0.93 for ranking people with Parkinson’s above healthy controls
- The catch:
- Only 26 healthy controls were included in the initial model comparison
Editor of record: Boris Djordjevic · AgingResearch.News
Among 133 people with Parkinson’s disease and 26 healthy controls in a U.S. cohort, an observational study used sleep and activity measures from everyday wrist-movement data to train a computer model. Its score for ranking people with Parkinson’s above healthy controls was 0.93.
Without retraining, the model scored 0.95 in an independent European cohort of 40 people, 50% with Parkinson’s, monitored using a different device. In U.S. groups at risk of Parkinson’s, it performed comparably to a clinical risk score in detecting problems in the system using dopamine, a brain signaling chemical, and disease-related changes involving the protein alpha-synuclein. Those analyses included 121 and 114 people, respectively. Combining the wearable model with the clinical score modestly improved detection.
Why it matters
Parkinson’s is an age-related disease that can impair sleep and movement early on. The authors support larger evaluations of wearable monitoring for screening and selecting research participants with disease-related biological markers.
Caveats
The initial comparison between people with Parkinson’s and healthy controls leaves performance in general-population screening open. The findings are from a preprint that has not been peer-reviewed.
Where the evidence stands
SNCA
- 59 independent labs in 21 countries
- 4 findings against
- 13 trials, 3 with no results posted
- Funders: National Natural Science Foundation of China and others
- 5 of 129 findings with company ties
- 12 of 13 trials sponsored by developers of drugs aimed at it
The paper
Department of Electrical and Computer Engineering, Faculty of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
medRxiv, Nov 15, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed
Comments
Be the first to comment.